arginine has been researched along with novobiocin in 25 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 11 (44.00) | 18.7374 |
1990's | 10 (40.00) | 18.2507 |
2000's | 1 (4.00) | 29.6817 |
2010's | 3 (12.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Bresnahan, D; Chalkley, R; Cotten, M; Sealy, L; Thompson, S | 1 |
Neuhard, J | 1 |
Nishikori, Y; Shimoyama, M; Tsuchiya, M; Yamada, K | 1 |
YUDKIN, MD | 1 |
Carvalho, DC; Garrido, SS; Marchetto, R; Scatigno, AC; Trovatti, E | 1 |
Constantinou, A; Grdina, D; Huberman, E; Kiguchi, K | 1 |
DeMarini, DM; Lawrence, BK | 1 |
Lorico, A; Rappa, G; Sartorelli, AC | 2 |
Adachi, K; Andrea, JE; Morgan, AR | 1 |
Schedl, P; Udvardy, A | 1 |
Chung, TD; Drake, FH; Hofmann, GA; Johnson, RK; Mattern, MR; Mirabelli, CK; Woessner, RD | 1 |
Elkind, MM; Shibuya, ML; Utsumi, H | 1 |
Baloch, Z; Coffman, FD; Cohen, S | 1 |
Desrosiers, R; Tanguay, RM | 1 |
Boyce, RA; Hertzberg, RP; Mattern, MR; Schein, PS; Tan, KB | 1 |
Legerski, RJ; Penkala, JE; Peterson, CA; Wright, DA | 1 |
Beerman, TA; Sigmund, RD; Woynarowski, JM | 1 |
Liu, LF; Rowe, TC; Yang, L | 1 |
Gottesfeld, JM | 1 |
Mui, SC; Strauss, PR; Todt, JC; Zhang, LH | 1 |
Lönn, S; Lönn, U | 1 |
25 other study(ies) available for arginine and novobiocin
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Novobiocin precipitates histones at concentrations normally used to inhibit eukaryotic type II topoisomerase.
Topics: Animals; Arginine; Cells, Cultured; Chemical Precipitation; Chromosomal Proteins, Non-Histone; Histones; In Vitro Techniques; Isoelectric Point; Liver Neoplasms, Experimental; Novobiocin; Osmolar Concentration; Protein Binding; Rats; Structure-Activity Relationship | 1986 |
Studies on the acid-soluble nucleotide pool in thymine-requiring mutants of Escherichia coli during thymine starvation. 3. On the regulation of the deoxyadenosine triphosphate and deoxycytidine triphosphate pools of Escherichia coli.
Topics: Adenosine Triphosphate; Arginine; Carbon Isotopes; Chromatography; Cytosine Nucleotides; Deoxyuridine; DNA, Bacterial; Escherichia coli; Floxuridine; Histidine; Methionine; Novobiocin; Nucleotides; Phosphorus Isotopes; Thymine; Uracil Nucleotides | 1966 |
Automodification of arginine-specific ADP-ribosyltransferase purified from chicken peripheral heterophils and alteration of the transferase activity.
Topics: Adenosine Diphosphate Ribose; Animals; Arginine; Chickens; Electrophoresis, Polyacrylamide Gel; Hydroxylamine; Hydroxylamines; Isoenzymes; Kinetics; Leukocytes; Molecular Weight; NAD; Novobiocin; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Substrate Specificity | 1994 |
THE EFFECT OF PENICILLIN, NOVOBIOCIN, STREPTOMYCIN AND VANCOMYCIN ON MEMBRANE SYNTHESIS BY PROTOPLASTS OF BACILLUS MEGATERIUM.
Topics: Antimetabolites; Arginine; Bacillus megaterium; Carbon Isotopes; Glycerol; Histidine; Muramidase; Novobiocin; Penicillin G; Penicillins; Proteins; Protoplasts; Research; Streptomycin; Tyrosine; Vancomycin | 1963 |
Probing the binding of the coumarin drugs using peptide fragments of DNA gyrase B protein.
Topics: Adenosine Triphosphate; Amino Acid Sequence; Arginine; Binding Sites; Binding, Competitive; Chromatography, Affinity; Coumarins; DNA Gyrase; Drug Design; Escherichia coli Proteins; Magnesium; Molecular Sequence Data; Novobiocin; Peptide Fragments | 2005 |
The effect of topoisomerase inhibitors on the expression of differentiation markers and cell cycle progression in human K-562 leukemia cells.
Topics: Amsacrine; Aphidicolin; Cell Cycle; Cell Differentiation; Cycloheximide; Deoxyadenosines; Dose-Response Relationship, Drug; Etoposide; G2 Phase; Hemoglobins; Humans; Kinetics; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Melanins; Mitosis; Novobiocin; Teniposide; Topoisomerase II Inhibitors; Tumor Cells, Cultured | 1992 |
Prophage induction by DNA topoisomerase II poisons and reactive-oxygen species: role of DNA breaks.
Topics: Amsacrine; Azides; Bacteriophage lambda; Dactinomycin; DNA Damage; Dose-Response Relationship, Drug; Doxorubicin; Ellipticines; Escherichia coli; Free Radicals; Hydrogen Peroxide; Lysogeny; Nalidixic Acid; Novobiocin; Oxolinic Acid; Oxygen; Paraquat; Sodium Azide; SOS Response, Genetics; Teniposide; Topoisomerase II Inhibitors; Virus Replication | 1992 |
Potentiation by novobiocin of the cytotoxic activity of etoposide (VP-16) and teniposide (VM-26).
Topics: Adenocarcinoma; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Cell Survival; DNA; DNA Topoisomerases, Type II; Drug Synergism; Etoposide; Humans; Leukemia; Lung Neoplasms; Novobiocin; RNA; Teniposide; Topoisomerase II Inhibitors; Tumor Cells, Cultured | 1992 |
Fluorometric assays for DNA topoisomerases and topoisomerase-targeted drugs: quantitation of catalytic activity and DNA cleavage.
Topics: Amsacrine; Animals; Antineoplastic Agents; Camptothecin; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; DNA, Circular; DNA, Single-Stranded; DNA, Superhelical; Ethidium; Fluorescence; Fluorometry; Hydrogen-Ion Concentration; Kinetics; Novobiocin; Teniposide; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors | 1991 |
Chromatin structure, not DNA sequence specificity, is the primary determinant of topoisomerase II sites of action in vivo.
Topics: Animals; Binding Sites; Cells, Cultured; Chromatin; DNA; DNA Topoisomerases, Type II; DNA, Ribosomal; Drosophila; Histones; Novobiocin; Nucleic Acid Conformation; Nucleosomes; RNA, Transfer; Teniposide | 1991 |
Differences between normal and ras-transformed NIH-3T3 cells in expression of the 170kD and 180kD forms of topoisomerase II.
Topics: Animals; Blotting, Northern; Blotting, Western; Cell Division; Cell Line; Cell Nucleus; Cell Transformation, Neoplastic; DNA Damage; DNA Topoisomerases, Type II; Genes, ras; Mice; Molecular Weight; Novobiocin; RNA, Messenger; Teniposide; Thiobarbiturates; Topoisomerase II Inhibitors | 1990 |
Novobiocin inhibits the repair of potentially lethal damage but not the repair of sublethal damage.
Topics: Amsacrine; Animals; Cell Line; Cricetinae; DNA Damage; DNA Repair; Etoposide; Novobiocin; Teniposide; Topoisomerase II Inhibitors | 1990 |
Induction of the differentiation of WEHI-3B D+ monomyelocytic leukemia cells by inhibitors of topoisomerase II.
Topics: Aclarubicin; Animals; Cell Cycle; Cell Differentiation; Doxorubicin; Leukemia, Myelomonocytic, Chronic; Mice; Novobiocin; Teniposide; Topoisomerase II Inhibitors; Tretinoin; Tumor Cells, Cultured | 1990 |
Synergistic interactions between tumor necrosis factor and inhibitors of DNA topoisomerase I and II.
Topics: Aminocoumarins; Camptothecin; Cell Line; Cell Survival; Coumarins; Drug Synergism; In Vitro Techniques; L Cells; Novobiocin; Teniposide; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Tumor Necrosis Factor-alpha | 1990 |
Transcriptional inhibitors affecting topoisomerase II induce changes in histone methylation patterns similar to those induced by heat shock.
Topics: Animals; Camptothecin; Cells, Cultured; Dactinomycin; Drosophila melanogaster; Ethidium; Histones; Hot Temperature; In Vitro Techniques; Methylation; Novobiocin; Teniposide; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Uridine | 1989 |
Elevated topoisomerase II activity and altered chromatin in nitrogen mustard-resistant human cells.
Topics: Amsacrine; Burkitt Lymphoma; Cell Line; Cell Survival; Chromatin; DNA Topoisomerases, Type II; Drug Resistance; Humans; Kinetics; Mechlorethamine; Novobiocin; Podophyllotoxin; Teniposide; Tumor Stem Cell Assay | 1987 |
Repair of UV-induced lesions in Xenopus laevis oocytes.
Topics: Animals; Camptothecin; Deoxycytosine Nucleotides; DNA; DNA Repair; DNA, Circular; DNA, Superhelical; Female; Kinetics; Microinjections; Novobiocin; Oocytes; Plasmids; Teniposide; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Transcription, Genetic; Ultraviolet Rays; Xenopus laevis | 1987 |
Topoisomerase-II-mediated lesions in nascent DNA: comparison of the effects of epipodophyllotoxin derivatives, VM-26 and VP-16, and 9-anilinoacridine derivatives, m-AMSA and o-AMSA.
Topics: Adenosine Triphosphate; Amsacrine; Animals; Cross-Linking Reagents; DNA; DNA Damage; DNA Replication; DNA Topoisomerases, Type II; DNA, Neoplasm; Etoposide; Leukemia L1210; Mice; Novobiocin; Podophyllotoxin; Teniposide; Topoisomerase II Inhibitors | 1988 |
Identification of DNA topoisomerase II as an intracellular target of antitumor epipodophyllotoxins in simian virus 40-infected monkey cells.
Topics: Animals; Cells, Cultured; Chemical Precipitation; DNA Topoisomerases, Type II; DNA, Viral; Etoposide; Haplorhini; Novobiocin; Podophyllotoxin; Simian virus 40; Teniposide | 1985 |
Novobiocin inhibits RNA polymerase III transcription in vitro by a mechanism distinct from DNA topoisomerase II.
Topics: Aminocoumarins; Camptothecin; Coumarins; DNA-Directed RNA Polymerases; HeLa Cells; Novobiocin; RNA Polymerase III; RNA, Ribosomal; RNA, Transfer; Teniposide; Topoisomerase II Inhibitors; Transcription, Genetic | 1986 |
Role for topoisomerases in the release of DNA into the detergent-soluble fraction of eukaryotic cells.
Topics: Aminoacridines; Amsacrine; Animals; Camptothecin; Detergents; DNA; DNA Topoisomerases, Type I; Intercalating Agents; Kinetics; Mice; Novobiocin; Solubility; Spleen; Teniposide; Thymidine | 1986 |
5,6-Dichloro-1-beta-O-ribofuranosylbenzimidazole induces DNA damage by interfering with DNA topoisomerase II.
Topics: Aphidicolin; Cells, Cultured; Chemical Precipitation; Dichlororibofuranosylbenzimidazole; Diterpenes; DNA; Electrophoresis, Agar Gel; Etoposide; Humans; Novobiocin; Proteins; Ribonucleosides; Teniposide; Topoisomerase II Inhibitors | 1987 |